TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

ADVENT CAPITAL MANAGEMENT /DE/'s Holding History (CIK: 0001097278)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 14,212,000 Value ($000) $20,388 Avg Close — Range —
Q3 2025
Shares 20,182,000 Value ($000) $22,855 Avg Close — Range —
Q2 2025
Shares 20,379,000 Value ($000) $19,462 Avg Close — Range —
Q1 2025
Shares 2,640,000 Value ($000) $2,637 Avg Close — Range —
Q3 2024
Shares 3,878,000 Value ($000) $3,351 Avg Close — Range —
Q3 2022
Shares 1,450,000 Value ($000) $1,483 Avg Close — Range —